Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 3500
Summary
- Conditions
- Heart Failure With Preserved Ejection Fraction
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 50 years and 99 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02901184
- Collaborators
- Karolinska University
- Duke Clinical Research Institute
- National Heart, Lung, and Blood Institute (NHLBI)
- Investigators
- Principal Investigator: Lars H Lund, MD, PhD Karolinska Institutet Principal Investigator: Bertram Pitt University of Michigan